Pune, India -- (SBWIRE) -- 02/17/2020 -- Global drugs of abuse (DOA) testing market is expected to rise to an estimated value of USD 11.54 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rise in the levels of developments, advancements along with innovative product launches by the major manufacturers.

Get Exclusive FREE Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-drugs-of-abuse-doa-testing-market&raksh

Few of the major competitors currently working in the global drugs of abuse (DOA) testing market are W.H.P.M., Inc.; WATERS; Laboratory Corporation of America Holdings; Abbott; Drägerwerk AG & Co. KGaA; Bio-Rad Laboratories, Inc.; Sonic Healthcare; bioMérieux SA; Danaher; Quest Diagnostics Incorporated; Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Randox Laboratories Ltd.; Psychemedics Corporation; Siemens Healthcare Private Limited; Merck KGaA; Ortho-Clinical Diagnostics; Biomedical diagnostics and Alfa Scientific Designs, Inc.

In this competitive age, an absolute as well as ample knowledge about the competitive landscape, product range of the competitors, their strategies, and future prospects are very important for businesses. Drugs of Abuse (DOA) Testing market research report serves the same and hence explains everything in detail that serves the business purpose and gives a competitive advantage. The report can be utilized to attain valuable market insights in a commercial way. Additionally, this Drugs of Abuse (DOA) Testing market report incorporates historic data, current market trends, market environment, technological innovation, upcoming technologies and the technical progress in the related industry.

To Get This Report at an Attractive Cost, Click Here https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-drugs-of-abuse-doa-testing-market&raksh

Market Definition: Global Drugs of Abuse (DOA) Testing Market:-

Drugs of abuse (DOA) testing is a diagnostic method of testing for substance or chemical abuse in individuals by testing the samples such as hair, saliva, urine, blood, breath. This is generally utilized for testing the usage of recreational drugs in the system of individuals so that they can be provided the correct course of treatment and clinical procedure can be undertaken.

Segmentation: Global Drugs of Abuse (DOA) Testing Market:-

Drugs of Abuse (DOA) Testing Market : By Product

Consumables
Equipment

Drugs of Abuse (DOA) Testing Market : By Sample Type

Urine
Saliva
Hair
Others

Drugs of Abuse (DOA) Testing Market : By Application

Pain Management
Criminal Justice
Workplace Screening

Drugs of Abuse (DOA) Testing Market : By End-Users

Hospitals
Laboratories
Workplace
At Home
Others

Drugs of Abuse (DOA) Testing Market : By Geography

North America
Europe
Asia-Pacific
South America
Middle East and Africa

Drugs of Abuse (DOA) Testing Market Drivers:-

Increasing consumption and trade of recreational drugs worldwide; this factor is expected to drive the growth of the market

Rise in the usage of products in various organizations to test their employees; this factor is expected to drive the growth of the market

Initiatives undertaken by various organizations and authorities for spreading awareness regarding the drug abuse and products to detect it; this factor is expected to drive the growth of the market

Drugs of Abuse (DOA) Testing Market Restraints:-

Transformation of laws to legalize the usage of recreational drugs/illicit drugs; this factor is expected to restrain the market growth

Lack of capabilities of these testing products for the detection of small amounts of special drugs; this factor is expected to restrain the growth of the market

Key Developments in the Drugs of Abuse (DOA) Testing Market:-

In September 2018, W.H.P.M., Inc. through its affiliate Carehealth America Corporation announced that they had acquired Express Diagnostics Int'l, Inc. This acquisition will significantly improve and complement the capabilities and technologies of both organizations leading to additions of product patents, trademarks and copyright.

In February 2018, Alfa Scientific Designs, Inc. announced that they had received US FDA 510(k) clearance for their "Instant-view-plus" multi-drug of abuse urine test. Alfa's "Driven Flow Technology" utilized in the simple cup DOA (drug-of-abuse) product termed as "Instant-view-plus iFOB". The clearance has been provided for usage in professional, CLIA-waived, and over-the-counter (OTC) usage. The product is capable of identifying thirteen individual drugs in approximately two minutes offering significant capabilities in comparison to the existing products in the market.

Drugs of Abuse (DOA) Testing Market : Competitive Analysis:-

Global drugs of abuse (DOA) testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drugs of abuse (DOA) testing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Products of the Report :-

Historical and current Drugs of Abuse (DOA) Testing market size and projection up to 2025.

Competitive landscape

Potential and specialty sections/districts showing promising development

The study provides an in-depth analysis of the global Drugs of Abuse (DOA) Testing market and current & future trends to elucidate imminent investment pockets.

Analyze and forecast Drugs of Abuse (DOA) Testing market on the basis of type, function and application.

Organization profiling of key players which incorporates business activities, item and administrations, geographic nearness, late advancements and key money related examination.

Table of Content: Drugs of Abuse (DOA) Testing Market:-

Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Global Drugs of Abuse (DOA) Testing Landscape
Part 04: Global Drugs of Abuse (DOA) Testing Sizing
Part 05: Global Drugs of Abuse (DOA) Testing Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

And More…..

Get Detailed TOC | at https://www.databridgemarketresearch.com/toc/?dbmr=global-drugs-of-abuse-doa-testing-market&raksh

About Data Bridge Market Research
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com